Brock Stewart

701 total citations
31 papers, 470 citations indexed

About

Brock Stewart is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Brock Stewart has authored 31 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 12 papers in Infectious Diseases and 6 papers in Health. Recurrent topics in Brock Stewart's work include Influenza Virus Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Hepatitis B Virus Studies (6 papers). Brock Stewart is often cited by papers focused on Influenza Virus Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Hepatitis B Virus Studies (6 papers). Brock Stewart collaborates with scholars based in United States, Uganda and Kenya. Brock Stewart's co-authors include Rongxia Li, Paige Lewis, Tom T. Shimabukuro, Maria Cano, Eric Weintraub, Jerome I. Tokars, Pedro L. Moro, Michael M. McNeil, Claudia Vellozzi and Adamma Mba‐Jonas and has published in prestigious journals such as Clinical Infectious Diseases, American Journal of Public Health and Journal of Hepatology.

In The Last Decade

Brock Stewart

29 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brock Stewart United States 14 256 183 91 91 39 31 470
Silvia Pérez-Vilar United States 15 341 1.3× 175 1.0× 61 0.7× 117 1.3× 49 1.3× 39 586
Yunzhou Fan China 10 191 0.7× 113 0.6× 94 1.0× 58 0.6× 53 1.4× 25 460
Dina Pfeifer United States 8 310 1.2× 157 0.9× 40 0.4× 231 2.5× 61 1.6× 10 517
Joelle I. Rosser United States 11 242 0.9× 111 0.6× 31 0.3× 59 0.6× 38 1.0× 23 435
Mike Gold Australia 6 132 0.5× 104 0.6× 133 1.5× 104 1.1× 39 1.0× 13 400
Daina B. Esposito United States 14 317 1.2× 231 1.3× 45 0.5× 192 2.1× 8 0.2× 38 768
Cinta de Diego‐Cabanes Spain 18 583 2.3× 145 0.8× 29 0.3× 75 0.8× 48 1.2× 54 780
Leigh M. Howard United States 15 323 1.3× 223 1.2× 24 0.3× 18 0.2× 41 1.1× 56 607
Katryn Paquette Canada 12 187 0.7× 186 1.0× 51 0.6× 11 0.1× 17 0.4× 19 577
Vasiliki Papaevangelou Greece 11 122 0.5× 91 0.5× 48 0.5× 13 0.1× 42 1.1× 20 405

Countries citing papers authored by Brock Stewart

Since Specialization
Citations

This map shows the geographic impact of Brock Stewart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brock Stewart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brock Stewart more than expected).

Fields of papers citing papers by Brock Stewart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brock Stewart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brock Stewart. The network helps show where Brock Stewart may publish in the future.

Co-authorship network of co-authors of Brock Stewart

This figure shows the co-authorship network connecting the top 25 collaborators of Brock Stewart. A scholar is included among the top collaborators of Brock Stewart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brock Stewart. Brock Stewart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Breakwell, Lucy, Reinhard Kaiser, Alexandra Tejada‐Strop, et al.. (2022). Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018. Vaccine. 40(19). 2741–2748. 7 indexed citations
5.
Khetsuriani, Nino, et al.. (2022). Diphtheria and tetanus seroepidemiology among children in Ukraine, 2017. Vaccine. 40(12). 1810–1820. 7 indexed citations
6.
Donadel, Morgane, et al.. (2021). Risk factors for measles deaths among children during a Nationwide measles outbreak – Romania, 2016–2018. BMC Infectious Diseases. 21(1). 279–279. 16 indexed citations
7.
Asay, Garrett R. Beeler, Brock Stewart, Joan M. Mangan, et al.. (2020). Cost of Tuberculosis Therapy Directly Observed on Video for Health Departments and Patients in New York City; San Francisco, California; and Rhode Island (2017–2018). American Journal of Public Health. 110(11). 1696–1703. 22 indexed citations
8.
Li, Rongxia, Brock Stewart, & Charles E. Rose. (2019). A Bayesian approach to sequential analysis in post‐licensure vaccine safety surveillance. Pharmaceutical Statistics. 19(3). 291–302. 5 indexed citations
9.
Araña, Jorge E., Theresa Harrington, Maria Cano, et al.. (2018). Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009–2015. Vaccine. 36(13). 1781–1788. 51 indexed citations
10.
Haber, Penina, Pedro L. Moro, Carmen S. Ng, et al.. (2017). Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005–2015. Vaccine. 36(4). 559–564. 11 indexed citations
11.
Sandul, Amy L., Mark N. Lobato, Suzanne M. Marks, et al.. (2017). High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection. Clinical Infectious Diseases. 65(7). 1085–1093. 69 indexed citations
12.
Moro, Pedro L., Christopher Jankosky, David Menschik, et al.. (2015). Adverse Events following Haemophilus influenzae Type b Vaccines in the Vaccine Adverse Event Reporting System, 1990-2013. The Journal of Pediatrics. 166(4). 992–997. 15 indexed citations
13.
Haber, Penina, Pedro L. Moro, Maria Cano, et al.. (2015). Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013–June 2014. Vaccine. 33(16). 1987–1992. 38 indexed citations
14.
Allen, Janet M., Alison H. Thomson, Baljit Dheansa, et al.. (2014). Dosing regimen of meropenem for adults with severe burns: a population pharmacokinetic study with Monte Carlo simulations. Journal of Antimicrobial Chemotherapy. 70(3). 882–890. 29 indexed citations
15.
Pan, Yi, Charles E. Rose, Michael Haber, et al.. (2013). Assessing Agreement of Repeated Binary Measurements with an Application to the CDC’s Anthrax Vaccine Clinical Trial. The International Journal of Biostatistics. 9(1). 19–32. 6 indexed citations
16.
Stewart, Brock, Yujia Zhang, Charles E. Rose, et al.. (2012). Health-related quality of life in the Anthrax Vaccination Program for workers in the Laboratory Response Network. Vaccine. 30(10). 1841–1846. 2 indexed citations
17.
McNeil, Michael M., Jorge E. Araña, Brock Stewart, et al.. (2012). A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination—Possible stimulated reporting?. Vaccine. 30(14). 2421–2426. 7 indexed citations
18.
Stewart, Brock, Charles E. Rose, Jerome I. Tokars, et al.. (2012). Health-related quality of life in the CDC Anthrax Vaccine Adsorbed Human Clinical Trial. Vaccine. 30(40). 5875–5879. 3 indexed citations
19.
Stewart, Brock, Lewis Jordan, & Rongxia Li. (2011). Comparing Traditional Longitudinal Modeling Strategies of Forestry with Mixed-Effects Models: Restrictions in Model Formulation. Forest Science. 57(5). 408–415. 2 indexed citations
20.
Rose, Charles E., et al.. (2011). Vaccination and risk of type 1 diabetes mellitus in active component U.S. Military, 2002–2008. Vaccine. 30(4). 813–819. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Pérez-Vilar Breakdown of academic impact, for papers by Yunzhou Fan Breakdown of academic impact, for papers by Dina Pfeifer Breakdown of academic impact, for papers by Joelle I. Rosser Breakdown of academic impact, for papers by Mike Gold Breakdown of academic impact, for papers by Daina B. Esposito Breakdown of academic impact, for papers by Cinta de Diego‐Cabanes Breakdown of academic impact, for papers by Leigh M. Howard Breakdown of academic impact, for papers by Katryn Paquette Breakdown of academic impact, for papers by Vasiliki Papaevangelou
Rankless by CCL
2026